US to Impose Steep Tariffs on Generic Medicine Imports From Aug 2028

India is expected to be among the countries most exposed to the proposed tariff regime.

Often referred to as the "pharmacy of the world", India is the largest supplier of generic medicines to the US. Indian drugmakers export around $9-10 billion worth of generic medicines to the American market every year, accounting for nearly 40% of all generic medicines used in the US.

According to India's commerce ministry, pharmaceutical exports to the US stood at $10.5 billion in 2024-25, making medicines one of India's top export categories to America.

A Global Trade Research Initiative (GTRI) report also estimated that India exported $9.7 billion worth of pharmaceuticals to the US in 2025, accounting for 38% of its global pharmaceutical exports.